MedTrace Logo

Molecular Testing to Direct Extent of Initial Thyroid Surgery

NCT02947035 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-07-14

No results posted yet for this study

Summary

The research study consists of the participant agreeing to 1) the use of preoperative molecular testing (ThyroSeq) to guide extent of initial surgery and 2) the prospective collection of medical record data related to treatment of thyroid cancer.

Conditions

Interventions

PROCEDURE

Thyroid lobectomy

Thyroid lobectomy is removal of only part of the thyroid

PROCEDURE

Total thyroidectomy with CCND

Total thyroidectomy with central compartment lymph node dissection is removal of the entire thyroid with the surrounding lymph nodes

Sponsors & Collaborators

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Linwah Yip, MD · University of Pittsburgh

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2023-06-01
Completion
2023-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02947035 on ClinicalTrials.gov